According to a new study being published in the upcoming issue of the journal Cannabis and Cannabinoid Research, and published online ahead of print by the National Library of Medicine, more than one-third of California adults use marijuana, with most reporting positive effects on their mental, emotional, and physical health. The research, conducted by scientists …
Category: Studies
Study: Marijuana Users Are Much More Likely to Exercise Than Drink or Eat Fast Food
A new survey challenges outdated stereotypes about marijuana users, showing they are far more likely to regularly work out than to drink alcohol or eat fast food. The poll, conducted by cannabis telehealth platform NuggMD, asked marijuana consumers about the frequency with which they engage in common lifestyle activities, including drinking, exercising, and eating fast …
Study: Cannabinoids Attached to Gold Nanoparticles Kill Breast Cancer Cells More Effectively Than Standard Form
Researchers from Toronto Metropolitan University and St. Michael’s Hospital have developed a method of delivering cannabinoids to cancer cells using gold nanoparticles, with results showing significantly enhanced anti-cancer effects in lab models. The study, published today by the journal Materials Today Sustainability, explored a new synthesis process for loading the cannabinoids THC and CBD onto …
Study: CBD Reverses Memory Impairment and Brain Changes Linked to Schizophrenia-Like Symptoms
A new study published in the journal Brain Research found that the cannabis compound cannabidiol (CBD) reversed memory deficits and brain abnormalities caused by schizophrenia-like conditions in an animal model. In the study, researchers from the University of São Paulo and the University of Saarland used the drug MK-801 to simulate schizophrenia symptoms in rats …
Clinical Trial Finds THC:CBD Spray Safe and Feasible for Treating Agitation in Alzheimer’s Patients
A new clinical trial has found that a THC:CBD oral spray may be a safe and practical treatment for agitation in patients with advanced Alzheimer’s disease. Conducted across care homes in the United Kingdom, the randomized, double-blind, placebo-controlled STAND trial evaluated the cannabinoid spray nabiximols (Sativex) as a potential therapy for agitation and aggression linked …
Study: CBD Slows HPV-Linked Head and Neck Cancer by Boosting Immune Response
A new preclinical study published in Frontiers in Immunology finds that cannabidiol (CBD) may help slow the growth of HPV-positive head and neck squamous cell carcinoma (HNSCC) by activating the immune system and disrupting cancer cell growth. Researchers at the University of California San Diego found that CBD significantly reduced tumor growth in mice with …
Study: Marijuana Use May Normalize Abnormal Brain Activity in People With HIV
A new study published in the Journal of Neuroimmune Pharmacology finds that regular marijuana use may help normalize abnormal brain activity linked to motor control deficits in people with HIV (PWH). The study involved 102 participants split into four groups: HIV-positive cannabis users, HIV-positive non-users, HIV-negative cannabis users, and HIV-negative non-users. Researchers used high-density magnetoencephalography …
Study Finds Majority of CBD Users in Germany Report Health Benefits, Minimal Side Effects
A strong majority of CBD users in Germany report health improvements and few adverse effects, according to a new study published in Frontiers in Pharmacology. Researchers from the University of Freiburg and University of Augsburg conducted an anonymous survey to explore why people are using over-the-counter CBD products and what effects they experience. The survey, …
Study: Cannabidiol (CBD) and Cannabidivarin (CBDV) Found to Kill Fungal Pathogens, Including Cryptococcus and Dermatophytes
New research shows that the cannabinoids CBD and CBDV have potent antifungal effects, including the ability to kill Cryptococcus neoformans and prevent biofilm formation. A study published in PLOS Neglected Tropical Diseases has found that cannabidiol (CBD) and cannabidivarin (CBDV) possess significant antifungal properties, particularly against the fungal pathogen Cryptococcus neoformans. Conducted by researchers from …
Johns Hopkins Launches First-Ever Psilocybin Trial for Stroke Recovery
Johns Hopkins University is launching a groundbreaking clinical trial exploring whether psilocybin-assisted therapy can help stroke survivors regain motor function—even years after their injury. The study is part of a new agreement between Johns Hopkins and Rose Hill Life Sciences, a company that holds exclusive rights to intellectual property surrounding psilocybin-based treatments for neurological damage. …
Sponsored
